For example, EPO has a short half-life (t1/2~5.6 h), and its affinity for EPOR2 is much higher than its affinity for EPOR/BcR; thus, side effects, such as polycythemia and thrombosis, can occur. The gene discussed is EPO; the disease is polycythemia.